These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17662610)
1. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Perez SE; Dar S; Ikonomovic MD; DeKosky ST; Mufson EJ Neurobiol Dis; 2007 Oct; 28(1):3-15. PubMed ID: 17662610 [TBL] [Abstract][Full Text] [Related]
2. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690 [TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173 [TBL] [Abstract][Full Text] [Related]
4. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824 [TBL] [Abstract][Full Text] [Related]
6. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. Hernandez D; Sugaya K; Qu T; McGowan E; Duff K; McKinney M Neuroreport; 2001 May; 12(7):1377-84. PubMed ID: 11388415 [TBL] [Abstract][Full Text] [Related]
7. Cholinergic neuropathology in a mouse model of Alzheimer's disease. German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807 [TBL] [Abstract][Full Text] [Related]
8. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468 [TBL] [Abstract][Full Text] [Related]
9. Selective loss of basal forebrain cholinergic neurons in APP770 transgenic mice. Li H; Shen X Chin Med J (Engl); 2000 Nov; 113(11):1040-2. PubMed ID: 11776121 [TBL] [Abstract][Full Text] [Related]
14. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Perez SE; He B; Muhammad N; Oh KJ; Fahnestock M; Ikonomovic MD; Mufson EJ Neurobiol Dis; 2011 Feb; 41(2):338-52. PubMed ID: 20937383 [TBL] [Abstract][Full Text] [Related]
15. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice. Kelley CM; Perez SE; Overk CR; Wynick D; Mufson EJ J Alzheimers Dis; 2011; 25(3):491-504. PubMed ID: 21471639 [TBL] [Abstract][Full Text] [Related]
16. Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Machová E; Rudajev V; Smycková H; Koivisto H; Tanila H; Dolezal V Neurobiol Dis; 2010 Apr; 38(1):27-35. PubMed ID: 20053373 [TBL] [Abstract][Full Text] [Related]
17. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
18. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
19. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease. Christensen DZ; Bayer TA; Wirths O Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817 [TBL] [Abstract][Full Text] [Related]